首页 / 资料库 / 文献详情

Hepatitis C virus:A global view

Amal Amal、Ahmed、Mohamed、Tamer、El-Bedewy、Magdy Magdy、El-Serafy、Naglaa

2015Acta Scientiarum Naturalium Universitatis SunyatseniMedicine被引 5

摘要

Hepatitis C virus(HCV) is a global challenge; 130-175 million are chronically infected. Over 350000 die each year from HCV. Chronic HCV is the primary cause of cirrhosis, hepatocellular carcinoma(HCC), and end-stage liver disease. Management of chronic HCV is aimed at preventing cirrhosis, reducing the risk of HCC, and treating extra hepatic complications. New treatments for chronic HCV has been devoted based on direct-acting antivirals, as pegylated interferon(peginterferon) is responsible for many side effects and limits treatment access. Sofosbuvir is the first compound to enter the market with Peginterferon-free combination regimens.

引用本文（GB/T 7714）